Reynders McVeigh Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $274K | Sell |
3,159
-549
| -15% | -$52.6K | 0.01% | 170 |
|
|
2025
Q4 | $356K | Buy |
3,708
+133
| +4% | +$12.9K | 0.02% | 145 |
|
|
2025
Q3 | $340K | Sell |
3,575
-5,926
| -62% | -$545K | 0.02% | 154 |
|
|
2025
Q2 | $828K | Sell |
9,501
-195,951
| -95% | -$16.6M | 0.04% | 110 |
|
|
2025
Q1 | $18.5M | Sell |
205,452
-5,633
| -3% | -$504K | 1.03% | 35 |
|
|
2024
Q4 | $16.9M | Sell |
211,085
-9,066
| -4% | -$785K | 0.89% | 38 |
|
|
2024
Q3 | $19.8M | Sell |
220,151
-3,528
| -2% | -$297K | 1.05% | 35 |
|
|
2024
Q2 | $17.6M | Sell |
223,679
-821
| -0.4% | -$67.3K | 1% | 35 |
|
|
2024
Q1 | $19.6M | Buy |
224,500
+10,403
| +5% | +$888K | 1.13% | 32 |
|
|
2023
Q4 | $17.6M | Sell |
214,097
-7,788
| -4% | -$594K | 1.12% | 31 |
|
|
2023
Q3 | $17.4M | Buy |
221,885
+22,105
| +11% | +$1.85M | 1.19% | 30 |
|
|
2023
Q2 | $17.6M | Buy |
199,780
+16,294
| +9% | +$1.4M | 1.15% | 30 |
|
|
2023
Q1 | $14.8M | Buy |
183,486
+34,819
| +23% | +$2.84M | 1.02% | 36 |
|
|
2022
Q4 | $11.6M | Sell |
148,667
-72,087
| -33% | -$5.84M | 0.85% | 37 |
|
|
2022
Q3 | $17.8M | Buy |
220,754
+238
| +0.1% | +$21.4K | 1.38% | 28 |
|
|
2022
Q2 | $19.8M | Buy |
220,516
+19,632
| +10% | +$1.99M | 1.48% | 27 |
|
|
2022
Q1 | $22.3M | Buy |
200,884
+24,670
| +14% | +$2.61M | 1.36% | 28 |
|
|
2021
Q4 | $18.2M | Sell |
176,214
-22,618
| -11% | -$2.62M | 1.03% | 33 |
|
|
2021
Q3 | $24.9M | Buy |
198,832
+26,713
| +16% | +$3.46M | 1.53% | 25 |
|
|
2021
Q2 | $21.4M | Buy |
172,119
+42,982
| +33% | +$5.4M | 1.31% | 26 |
|
|
2021
Q1 | $15.3M | Buy |
129,137
+107,990
| +511% | +$12.7M | 1.02% | 33 |
|
|
2020
Q4 | $2.48M | Buy |
21,147
+14,331
| +210% | +$1.58M | 0.17% | 66 |
|
|
2020
Q3 | $708K | Sell |
6,816
-1,358
| -17% | -$136K | 0.05% | 123 |
|
|
2020
Q2 | $750K | Buy |
8,174
+2,225
| +37% | +$213K | 0.07% | 118 |
|
|
2020
Q1 | $536K | Buy |
5,949
+2
| +0% | +$213 | 0.06% | 117 |
|
|
2019
Q4 | $675K | Sell |
5,947
-64
| -1% | -$7.02K | 0.07% | 135 |
|
|
2019
Q3 | $653K | Sell |
6,011
-113
| -2% | -$11.8K | 0.07% | 126 |
|
|
2019
Q2 | $596K | Sell |
6,124
-168
| -3% | -$15.3K | 0.06% | 130 |
|
|
2019
Q1 | $573K | Buy |
6,292
+161
| +3% | +$14.4K | 0.06% | 135 |
|
|
2018
Q4 | $558K | Sell |
6,131
-300
| -5% | -$28K | 0.07% | 123 |
|
|
2018
Q3 | $633K | Sell |
6,431
-100
| -2% | -$9.24K | 0.07% | 125 |
|
|
2018
Q2 | $559K | Sell |
6,531
-302
| -4% | -$25.2K | 0.07% | 128 |
|
|
2018
Q1 | $548K | Buy |
6,833
+300
| +5% | +$24.7K | 0.07% | 127 |
|
|
2017
Q4 | $528K | Sell |
6,533
-150
| -2% | -$12K | 0.07% | 133 |
|
|
2017
Q3 | $520K | Hold |
6,683
| – | – | 0.07% | 132 |
|
|
2017
Q2 | $593K | Sell |
6,683
-300
| -4% | -$25.3K | 0.08% | 123 |
|
|
2017
Q1 | $563K | Sell |
6,983
-57
| -0.8% | -$4.45K | 0.08% | 133 |
|
|
2016
Q4 | $501K | Buy |
7,040
+127
| +2% | +$9.98K | 0.07% | 140 |
|
|
2016
Q3 | $597K | Sell |
6,913
-150
| -2% | -$13.1K | 0.09% | 130 |
|
|
2016
Q2 | $613K | Buy |
7,063
+43
| +0.6% | +$3.48K | 0.09% | 130 |
|
|
2016
Q1 | $526K | Buy |
7,020
+924
| +15% | +$69.6K | 0.08% | 136 |
|
|
2015
Q4 | $469K | Buy |
6,096
+37
| +0.6% | +$2.79K | 0.08% | 126 |
|
|
2015
Q3 | $406K | Sell |
6,059
-100
| -2% | -$7.37K | 0.07% | 138 |
|
|
2015
Q2 | $456K | Buy |
6,159
+100
| +2% | +$7.64K | 0.07% | 134 |
|
|
2015
Q1 | $473K | Sell |
6,059
-333
| -5% | -$25.2K | 0.08% | 126 |
|
|
2014
Q4 | $462K | Hold |
6,392
| – | – | 0.08% | 126 |
|
|
2014
Q3 | $396K | Buy |
6,392
+1,400
| +28% | +$89K | 0.08% | 129 |
|
|
2014
Q2 | $318K | Sell |
4,992
-50
| -1% | -$3.04K | 0.07% | 137 |
|
|
2014
Q1 | $310K | Hold |
5,042
| – | – | 0.07% | 136 |
|
|
2013
Q4 | $289K | Hold |
5,042
| – | – | 0.07% | 140 |
|
|
2013
Q3 | $268K | Hold |
5,042
| – | – | 0.07% | 137 |
|
|
2013
Q2 | $260K | Buy |
+5,042
| New | +$249K | 0.08% | 134 |
|
Other funds holding MDT
VCM
VPM
Reynders McVeigh Capital Management's MDT Position: Q1 2026 in Review
Reynders McVeigh Capital Management reduced its Medtronic (MDT) stake by 15% in Q1 2026, selling an estimated $52.6K and leaving 3,159 shares worth $274K. The position accounts for 0.01% of the portfolio, ranked #170.
Reynders McVeigh Capital Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.9M in Q3 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Reynders McVeigh Capital Management held 3,159 shares of Medtronic worth $274K as of Q1 2026.
- Reynders McVeigh Capital Management sold 549 Medtronic shares in Q1 2026, an estimated $52.6K.
- Medtronic made up 0.01% of Reynders McVeigh Capital Management's portfolio in Q1 2026, its #170 holding.
- Reynders McVeigh Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Reynders McVeigh Capital Management's Medtronic position peaked at $24.9M in Q3 2021.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Reynders McVeigh Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.